SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Titan Biotech informs about outcome of board meeting

03 Jan 2026 Evaluate
Titan Biotech has informed that the Board of Directors of the Company, at its meeting held on 02nd January, 2026 has approved and reconstituted the following Committees of the Board with effect from 02nd January, 2026: a) Reconstitution of the Audit Committee by appointing Brijesh Kumar Singh and Debendra Kumar Sabat as Member of the Committee with effective from 02nd January, 2026. Post reconstitution, the composition of the Audit Committee with effective from 02nd January, 2026. Details enclosed.

The above information is a part of company’s filings submitted to BSE.

Titan Bio-Tech Share Price

474.60 22.60 (5.00%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3703.10
Tata Chemicals 709.05
SRF 2493.65
Pidilite Inds. 1393.25
Deepak Nitrite 1538.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×